MetLife Investment Management LLC Sells 32,388 Shares of The Procter & Gamble Company (NYSE:PG)

MetLife Investment Management LLC reduced its position in shares of The Procter & Gamble Company (NYSE:PG) by 5.0% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 616,646 shares of the company’s stock after selling 32,388 shares during the quarter. Procter & Gamble comprises about 0.7% of MetLife Investment Management LLC’s portfolio, making the stock its 19th biggest position. MetLife Investment Management LLC’s holdings in Procter & Gamble were worth $93,570,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. GW&K Investment Management LLC purchased a new position in Procter & Gamble during the 1st quarter worth $28,000. Your Advocates Ltd. LLP increased its holdings in Procter & Gamble by 632.0% during the 2nd quarter. Your Advocates Ltd. LLP now owns 183 shares of the company’s stock worth $28,000 after purchasing an additional 158 shares during the period. Ten Capital Wealth Advisors LLC increased its holdings in shares of Procter & Gamble by 325.8% in the 1st quarter. Ten Capital Wealth Advisors LLC now owns 264 shares of the company’s stock valued at $39,000 after acquiring an additional 202 shares during the period. Wunderlich Capital Managemnt purchased a new position in shares of Procter & Gamble in the 2nd quarter valued at $40,000. Finally, Silicon Valley Capital Partners increased its holdings in shares of Procter & Gamble by 51.3% in the 1st quarter. Silicon Valley Capital Partners now owns 283 shares of the company’s stock valued at $42,000 after acquiring an additional 96 shares during the period. 63.43% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, CEO R. Alexandra Keith sold 19,661 shares of the company’s stock in a transaction dated Tuesday, November 14th. The stock was sold at an average price of $153.47, for a total value of $3,017,373.67. Following the completion of the transaction, the chief executive officer now owns 24,438 shares of the company’s stock, valued at approximately $3,750,499.86. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Procter & Gamble news, insider Susan Street Whaley sold 884 shares of the business’s stock in a transaction that occurred on Thursday, August 24th. The stock was sold at an average price of $154.49, for a total transaction of $136,569.16. Following the completion of the sale, the insider now directly owns 8,073 shares in the company, valued at approximately $1,247,197.77. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, CEO R. Alexandra Keith sold 19,661 shares of the business’s stock in a transaction that occurred on Tuesday, November 14th. The stock was sold at an average price of $153.47, for a total value of $3,017,373.67. Following the sale, the chief executive officer now owns 24,438 shares of the company’s stock, valued at $3,750,499.86. The disclosure for this sale can be found here. In the last 90 days, insiders sold 96,088 shares of company stock valued at $14,565,908. 0.17% of the stock is owned by company insiders.

Procter & Gamble Stock Performance

Shares of PG stock traded down $0.86 on Monday, hitting $150.21. The company had a trading volume of 1,584,099 shares, compared to its average volume of 6,202,781. The firm has a market cap of $354.03 billion, a P/E ratio of 24.48, a price-to-earnings-growth ratio of 3.16 and a beta of 0.47. The company has a 50-day moving average price of $149.28 and a 200-day moving average price of $150.65. The company has a quick ratio of 0.48, a current ratio of 0.67 and a debt-to-equity ratio of 0.51. The Procter & Gamble Company has a twelve month low of $135.83 and a twelve month high of $158.38.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings data on Wednesday, October 18th. The company reported $1.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.71 by $0.12. The business had revenue of $21.87 billion during the quarter, compared to analysts’ expectations of $21.58 billion. Procter & Gamble had a return on equity of 33.49% and a net margin of 18.30%. The company’s revenue for the quarter was up 6.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.57 EPS. As a group, equities research analysts predict that The Procter & Gamble Company will post 6.42 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, November 15th. Investors of record on Friday, October 20th were issued a $0.9407 dividend. The ex-dividend date of this dividend was Thursday, October 19th. This represents a $3.76 dividend on an annualized basis and a yield of 2.51%. Procter & Gamble’s payout ratio is 61.04%.

Analyst Upgrades and Downgrades

PG has been the topic of a number of analyst reports. Wells Fargo & Company lifted their price target on Procter & Gamble from $160.00 to $162.00 and gave the company an “overweight” rating in a report on Thursday, October 19th. Deutsche Bank Aktiengesellschaft lifted their price target on Procter & Gamble from $170.00 to $173.00 and gave the company a “buy” rating in a report on Monday, July 31st. Stifel Nicolaus dropped their target price on Procter & Gamble from $161.00 to $151.00 and set a “hold” rating on the stock in a research note on Monday, October 16th. DZ Bank upgraded Procter & Gamble from a “sell” rating to a “hold” rating and set a $155.00 target price on the stock in a research note on Friday, October 20th. Finally, StockNews.com upgraded Procter & Gamble from a “hold” rating to a “buy” rating in a research note on Monday, November 6th. Six investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. Based on data from MarketBeat, Procter & Gamble currently has a consensus rating of “Moderate Buy” and a consensus price target of $165.83.

About Procter & Gamble

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.